Cancer Cytogenetics
Under the leadership of Michelle Afkhami, M.D., the Cytogenetics Service performs over 8,000 diagnostic cancer cytogenetic and fluorescence in situ hybridization (FISH) procedures annually with an overall abnormality rate of approximately 32.2 percent. Testing to detect and characterize leukemias, lymphomas and solid tumors is performed on fresh and archival FFPE (formalin-fixed, paraffin-embedded) tissues.
Cytogenetics is certified under the Clinical Laboratory Improvements Amendments of 1988 (CLIA ID No. 05D2302026), licensed by the State of California (CDF 90012253), and accreditation pending by the College of American Pathologists.
- Cytogenetics Hematopathology
- Cytogenetics Solid Tumor
Cytogenetics Faculty
Dr. Afkhami is chief of the Division of Molecular Pathology and Therapy Biomarkers, Department of Pathology, at City of Hope in Duarte, California.